Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors
Markets

Proactive news summary: Summit Therapeutics, Mirada, NetScientific, Solo Oil and more

An update from Solo Oil at Horse Hill, Metal Tiger commences new drilling and Mirada makes it to Mexico.
757z468_newsppaers_56c499ff38f08.png
Daily news round-up from the world of Proactive
Utilitywise (LON:UTW), which arranges energy and water for businesses, traded in line with forecasts in the first half, with continued revenue growth from the UK and European arms.
 
The company said “significant momentum has been achieved” in the past six months, particularly in the enterprise division, with the gross order book growing by £40mln in the six months to January 31.
 
The revenue pipeline, meanwhile, was £24.7mln.
 
This morning, Solo Oil (LON:SOLO) said the initial flow rate had been maintained for a second day from the Horse Hill discovery well. 
 
“Two further intervals are yet to be tested and we look forward to further news in the coming days” said chairman Neil Ritson.
 
Meanwhile, Savannah Petroleum (LON:SAVP) has told investors that framework contracts have now been signed for planned seismic exploration programmes in Niger.
 
Contractor BGP Niger SARL will now provide 2D and 3D land seismic acquisition services for Savannah’s licence areas in South East Niger. 
 
Resources investment group Metal Tiger (LON:MTR) has commenced drilling at the Kalahari copper belt joint venture in Botswana.
 
The first phase will target T4 with five others, where there has been no or minimal drilling to date, to be drilled as the project progresses.
 
Additionally, Metminco (LON:MNC) has started to drill the TD2 Target at its Los Calatos copper deposit in southern Peru.
 
Surface mapping identified the presence of copper oxides that soil samples indicated was a well-developed copper anomaly similar in character to Los Calatos.
 
Results from metallurgical test work at Kibo Mining's (LON:KIBO) Mbeya coal resource have increased management's confidence in the coal-to-power project in Tanzania.
 
All the consulting experts concluded that the coal metallurgy and quality was suitable for use in a fluidised bed coal power station.
 
Summit Therapeutics (LON:SUMM) is to take part in one-on-one meetings at the SunTrust Robinson Humphrey’s 2016 Orphan Drug Day in New York at the end of the month.
 
After 18 months in development,  Mirada (LON:MIRA) has commercially launched its over-the-top (OTT) content solution for izzi Telecom in Mexico.
 
NetScientific (LON:NSCI) has added some heavyweight medical and commercialisation expertise to its board with the appointment of Professor Stephen Smith as a non-executive director.
 
Professor Smith has had a long and distinguished career as a clinician scientist, head of department, dean and chief executive officer with the Medical Research Council.
 
And finally, Obtala Resources (LON:OBT) has received a US$3mln investment into its Mozambique forestry business from three specialist timber investors.
 
As a result of the investment, Obtala has postponed plans to spin off Argento, its forestry arm.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use